What is the total value of India's pharmaceutical export to Guadeloupe?

India exported pharmaceuticals worth $1.1K to Guadeloupe across 4 verified shipments.

Who are the top Indian pharmaceutical exporters to Guadeloupe?

1. GRENERA NUTRIENTS PRIVATE LIMITED — $1.1K. Total: 1 suppliers.

Which companies in Guadeloupe import pharmaceuticals from India?

1. MR.PURCHASE MANAGER GUADELOUPE — $1.1K. 1 buyers total.

What pharmaceutical products does India export most to Guadeloupe?

1. Moringa Capsules (total-350 Pcs)batch No: Mc224002)mfgdate: 02/02/2024,exp Date… ($299, 26.0%); 2. Moringa Assorted Infusion(20dipsperbox)(total-360 Pcs)batch No: Masi223012)mfg… ($299, 26.0%); 3. Slimming Tea(30 Dips Per Box) (total - 400 Pcs) Batch No: Slt223001)mfg Date: 2… ($276, 24.0%); 4. Moringa Pomegranate Infusion(18dipsperbox)(total - 280pcs)batch No: Mpi223012)m… ($276, 24.0%)

Which ports handle pharmaceutical shipments from India to Guadeloupe?

Export: TUTICORIN ICD. Import: POINTE-¿-PITRE.

Why does Guadeloupe import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $1.1K corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Guadeloupe?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Guadeloupe pharmaceutical trade?

$287 per consignment across 4 shipments.

How many Indian pharmaceutical companies export to Guadeloupe?

1 Indian companies. Largest: GRENERA NUTRIENTS PRIVATE LIMITED with $1.1K.

How can I find verified Indian pharmaceutical suppliers for Guadeloupe?

TransData Nexus covers 1 active exporters with shipment history and trade values at transdatanexus.com.

India to Guadeloupe Pharmaceutical Export (2026) — $1.1K, 1 Suppliers | TransData Nexus

India to Guadeloupe Pharmaceutical Export (2026) — $1.1K, 1 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Guadeloupe

#	Formulation	Value	Share
1	Moringa Capsules (total-350 Pcs)batch No: Mc224002)mfgdate: 02/02/2024,exp Date…	$299	26.0%
2	Moringa Assorted Infusion(20dipsperbox)(total-360 Pcs)batch No: Masi223012)mfg…	$299	26.0%
3	Slimming Tea(30 Dips Per Box) (total - 400 Pcs) Batch No: Slt223001)mfg Date: 2…	$276	24.0%
4	Moringa Pomegranate Infusion(18dipsperbox)(total - 280pcs)batch No: Mpi223012)m…	$276	24.0%

India exports 4+ pharmaceutical formulations to Guadeloupe with a combined trade value of $1.1K.. These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 4 verified Indian Customs (DGFT) shipment records.

Top Indian Exporters to Guadeloupe

1Grenera Nutrients Private Limited

$1K

1 Indian pharmaceutical companies export finished formulations to Guadeloupe. Leading exporters include Grenera Nutrients Private Limited, . The top exporter accounts for 100.0% of total India–Guadeloupe pharma exports. Source: Indian Customs (DGFT).

Top Guadeloupe Buyers from India

1Mr.purchase Manager Guadeloupe

$1K

1 companies in Guadeloupe import pharmaceutical formulations from India. Top buyers include Mr.purchase Manager Guadeloupe, . The largest buyer accounts for 100.0% of India–Guadeloupe pharma imports. Source: Indian Customs (DGFT).

Port Analysis — India to Guadeloupe Pharmaceutical Shipments

Indian Export Ports

TUTICORIN ICD100.0%

Guadeloupe Import Ports

POINTE-¿-PITRE100.0%

Trade Statistics

Total Value$1K

Shipments4

Indian Exporters1

Guadeloupe Buyers1

Avg Shipment$287

Products4

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B France

Last updated: March 28, 2026

Supply Chain & Logistics — India to Guadeloupe Pharma Shipments

Shipping routes, port infrastructure, cold chain compliance

1Shipping Routes & Transit

Pharmaceutical shipments from India to Guadeloupe primarily utilize sea and air transport. The main sea route involves departing from Tuticorin International Container Depot (ICD) in Tamil Nadu, India, and arriving at Pointe-à-Pitre in Guadeloupe. This journey typically spans approximately 20 to 25 days, depending on the specific shipping line and any transshipment points. Air freight, though less common due to higher costs, offers a faster alternative with transit times of around 7 to 10 days.

Recent disruptions in the Red Sea have impacted global shipping routes, potentially affecting transit times and costs for shipments from India to Guadeloupe. While the direct impact on this specific corridor is yet to be fully assessed, it's advisable to monitor the situation closely and consult with shipping partners for the most current information.

2Port Infrastructure

Tuticorin ICD, located in Tamil Nadu, India, serves as the sole export port for pharmaceutical shipments to Guadeloupe. This port is equipped with modern facilities capable of handling various cargo types, including temperature-sensitive pharmaceuticals. Pointe-à-Pitre, situated on the island of Grande-Terre in Guadeloupe, is the exclusive import port for these shipments. As the primary maritime gateway in Guadeloupe, Pointe-à-Pitre is well-equipped to handle international cargo, including pharmaceuticals, ensuring efficient processing and distribution.

Market Opportunity Assessment — Guadeloupe for Indian Pharma

Market size, healthcare system, growth outlook

1Market Size & Growth

Guadeloupe's pharmaceutical market is relatively small but exhibits steady growth. As of recent estimates, the market is valued at approximately $50 million, with an expected annual growth rate of 4-5% over the next five years. This growth is driven by increased healthcare spending, a rising prevalence of chronic diseases, and government initiatives to enhance healthcare infrastructure.

The market is heavily import-dependent, with limited local pharmaceutical production. This dependency underscores the potential for foreign suppliers, particularly from India, to meet the growing demand for pharmaceutical products. Regarding generic drug penetration, the Caribbean region, including Guadeloupe, has a relatively low generic-to-branded drug ratio compared to global standards. In the Caribbean, generics account for 38% of the pharmaceutical market by value, while branded drugs constitute 62%. This indicates a significant opportunity for generic drug manufacturers to expand their presence in the market.

2Healthcare System

Guadeloupe operates under a universal healthcare system, similar to mainland France, ensuring comprehensive medical care for all residents. Healthcare services are primarily funded through the French social security system (Assurance Maladie), which reimburses a substantial portion of medical expenses, including doctor visits, hospital stays, and medications. Residents utilize the Carte Vitale, a health insurance card that facilitates the reimbursement process.

The Regional Health Agency (ARS) of Guadeloupe oversees the regional management of the healthcare system, aligning with national guidelines and addressing local health needs. The ARS is responsible for public health policy, regulating healthcare provision, and fostering collaborations among healthcare professionals to enhance service delivery. (gnius.esante.gouv.fr)

3Opportunity for Indian Exporters

The limited local pharmaceutical production in Guadeloupe presents a significant opportunity for Indian pharmaceutical exporters to supply a variety of products, particularly generic medications. The top Indian exporter to Guadeloupe, Grenera Nutrients Private Limited, has engaged in four shipments valued at $1,000, primarily consisting of herbal supplements such as Moringa Capsules and Assorted Infusions. These products have demonstrated a 26% share in the market, indicating a growing acceptance of herbal and natural supplements among the Guadeloupean population.

The low generic drug penetration rate in the Caribbean suggests a substantial market for generic pharmaceuticals. Indian exporters can capitalize on this by offering cost-effective generic drugs to meet the rising demand. Additionally, the steady growth of the pharmaceutical market, driven by increased healthcare spending and a higher prevalence of chronic diseases, provides a favorable environment for expanding exports. By aligning with the regulatory standards set by the National Drug Regulatory Authority (WHO-GMP) in Guadeloupe, Indian pharmaceutical companies can establish a strong foothold in this emerging market.

TransData Nexus Research · Guadeloupe healthcare dataMar 2026

Competitive Landscape — India vs Other Pharmaceutical Suppliers to Guadeloupe

Competing origins, India's edge, challenges and threats

1Competing Origins

Guadeloupe's pharmaceutical market is predominantly supplied by manufacturers from China, the European Union (EU), and domestic producers. China and the EU are significant contributors, offering a wide range of pharmaceutical products. Domestic production in Guadeloupe is limited, leading to a reliance on imports to meet the healthcare needs of the population. Specific market share data for these suppliers is not readily available.

India's pharmaceutical exports to Guadeloupe are relatively modest, with a total export value of $1,000 USD over four shipments, averaging $287 per shipment. This indicates that while India is a participant in the market, its share is currently small compared to other origins.

2India's Competitive Edge

India's pharmaceutical industry is renowned for its cost competitiveness, offering affordable medicines without compromising on quality. The country's adherence to Good Manufacturing Practices (GMP), including WHO-GMP compliance, ensures that products meet international standards. Additionally, India's English-speaking workforce facilitates smoother communication and collaboration with international partners. The industry's broad portfolio, encompassing generics, branded drugs, and specialized formulations, allows it to cater to diverse market needs.

3Challenges & Threats

Indian pharmaceutical exporters face several challenges in Guadeloupe. Regulatory tightening, particularly adherence to WHO-GMP standards, requires continuous compliance efforts. Competition from China, which offers a vast array of pharmaceutical products, poses a threat to India's market share. Additionally, perceptions regarding the quality of Indian pharmaceuticals can impact their acceptance in the market. Addressing these challenges is crucial for enhancing India's position in Guadeloupe's pharmaceutical sector.

TransData Nexus Research · Global trade databasesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Guadeloupe identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 4 verified shipments from 1 Indian exporters to 1 Guadeloupe buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

1 Exporters

1 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Guadeloupe Pharmaceutical Export